Pathophysiology of migraine

Seminars in Neurology

Volumn 30, Issue 2, 2010, Pages 120-130

  Cutrer, F Michael ^a  

^a MAYO CLINIC   (United States)

Author keywords

Aura; Central sensitization; Migraine; Pathophysiology

Indexed keywords

ATENOLOL; PROPRANOLOL;

BRAIN BLOOD VESSEL; BRAIN CORTEX; BRAIN FUNCTION; DISEASE COURSE; DRUG MECHANISM; GENETIC PREDISPOSITION; HEADACHE; HUMAN; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NEUROANATOMY; NOCICEPTION; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SENSITIZATION; WHITE MATTER;

BRAIN; BRAIN STEM; CEREBRAL ARTERIES; CEREBRAL CORTEX; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; MIGRAINE WITH AURA; NEURAL PATHWAYS; NOCICEPTORS; TRIGEMINAL NERVE;

EID: 77950528556     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0030-1249222     Document Type: Review

References (104)

1. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia 2004 24 (Suppl 1) 9-160
2. Penfield W. A contribution to the mechanism of intracranial pain. Association for Research in Nervous and Mental Disease Proceedings (1934) 1935 15 399-416
3. Ray B S., Wolff H G. Experimental studies on headache. Pain-sensitive structures of the head and their significance in headache. Arch Surg 1940 41 813-856
4. Mayberg M R., Zervas N T., Moskowitz M A. Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J Comp Neurol 1984 223 (1) 46-56
5. Nozaki K, Boccalini P, Moskowitz M A. Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space. Neuroscience 1992 49 (3) 669-680
6. DaSilva A FM, Becerra L, Makris N et al. Somatotopic activation in the human trigeminal pain pathway. J Neurosci 2002 22 (18) 8183-8192
7. Sessle B J., Hu J W., Dubner R, Lucier G E. Functional properties of neurons in cat trigeminal subnucleus caudalis (medullary dorsal horn). II. Modulation of responses to noxious and nonnoxious stimuli by periaqueductal gray, nucleus raphe magnus, cerebral cortex, and afferent influences, and effect of nalaxone. J Neurophysiol 1981 45 193-207
8. Kruger L, Young R F. Specialized features of the trigeminal nerve and its central connections In: Samii M, Janetta PJ The Cranial Nerves. Berlin Springer-Verlag 1981 273-301
9. Wise S P., Jones E G. Cells of origin and terminal distribution of descending projections of the rat somatic sensory cortex. J Comp Neurol 1977 175 (2) 129-157
10. Jacquin M F., Chiaia N L., Haring J H., Rhoades R W. Intersubnuclear connections within the rat trigeminal brainstem complex. Somatosens Mot Res 1990 7 (4) 399-420
11. Renehan W E., Jacquin M F., Mooney R D., Rhoades R W. Structure-function relationships in rat medullary and cervical dorsal horns. II. Medullary dorsal horn cells. J Neurophysiol 1986 55 (6) 1187-1201
12. Weiller C, May A, Limmroth V et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995 1 (7) 658-660
13. Wolff H G. Headache and Other Head Pain. 2nd ed. New York Oxford University Press 1963
14. Diener H C., RPR100893 Study Group. RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks. Cephalalgia 2003 23 (3) 183-185
15. Kruuse C, Thomsen L L., Birk S, Olesen J. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain 2003 126 (Pt 1) 241-247
16. Schoonman G G., van der Grond J, Kortmann C, van der Geest R J., Terwindt G M., Ferrari M D. Migraine headache is not associated with cerebral or meningeal vasodilatationa 3T magnetic resonance angiography study. Brain 2008 131 (Pt 8) 2192-2200
17. Rahmann A, Wienecke T, Hansen J M., Fahrenkrug J, Olesen J, Ashina M. Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia 2008 28 (3) 226-236
18. Woods R P., Iacoboni M, Mazziotta J C. Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994 331 (25) 1689-1692
19. Cutrer F M., Sorensen A G., Weisskoff R M. et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 1998 43 (1) 25-31
20. Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Posterior cerebral hypoperfusion in migraine without aura. Cephalalgia 2008 28 (8) 856-862
21. Cutrer F M., Charles A. The neurogenic basis of migraine. Headache 2008 48 (9) 1411-1414
22. Ophoff R A., Terwindt G M., Vergouwe M N. et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+channel gene CACNL1A4. Cell 1996 87 (3) 543-552
23. De Fusco M, Marconi R, Silvestri L et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003 33 (2) 192-196
24. Dichgans M, Freilinger T, Eckstein G et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005 366 (9483) 371-377
25. Kusumi M, Ishizaki K, Kowa H et al. Glutathione S-transferase polymorphisms: susceptibility to migraine without aura. Eur Neurol 2003 49 (4) 218-222
26. Kara I, Sazci A, Ergul E, Kaya G, Kilic G. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res 2003 17;111 (12) 84-90
27. Wessman M, Kallela M, Kaunisto M A. et al. A susceptibility locus for migraine with aura, on chromosome 4q24. Am J Hum Genet 2002 70 (3) 652-662
28. Bjrnsson A, Gudmundsson G, Gudfinnsson E et al. Localization of a gene for migraine without aura to chromosome 4q21. Am J Hum Genet 2003 73 (5) 986-993
29. Tzourio C, El Amrani M, Poirier O, Nicaud V, Bousser M G., Alprovitch A. Association between migraine and endothelin type A receptor (ETA -231 A/G) gene polymorphism. Neurology 2001 56 (10) 1273-1277
30. Carlsson A, Forsgren L, Nylander P-O et al. Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1. Neurology 2002 59 (11) 1804-1807
31. Rainero I, Grimaldi L M., Salani G et al. Association between the tumor necrosis factor-alpha -308 G/A gene polymorphism and migraine. Neurology 2004 62 (1) 141-143
32. Rainero I, Fasano E, Rubino E et al. Association between migraine and HLA-DRB1 gene polymorphisms. J Headache Pain 2005 6 (4) 185-187
33. Colson N J., Lea R A., Quinlan S, MacMillan J, Griffiths L R. The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups. Neurogenetics 2004 5 (2) 129-133
34. Oterino A, Pascual J, Ruiz de Alegra C et al. Association of migraine and ESR1 G325C polymorphism. Neuroreport 2006 17 (1) 61-64
35. Lea R A., Dohy A, Jordan K, Quinlan S, Brimage P J., Griffiths L R. Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine. Neurogenetics 2000 3 (1) 35-40
36. Cader Z M., Noble-Topham S, Dyment D A. et al. Significant linkage to migraine with aura on chromosome 11q24. Hum Mol Genet 2003 12 (19) 2511-2517
37. Mochi M, Cevoli S, Cortelli P et al. A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta- hydroxylase genes. Neurol Sci 2003 23 (6) 301-305
38. Colson N J., Lea R A., Quinlan S, MacMillan J, Griffiths L R. Investigation of hormone receptor genes in migraine. Neurogenetics 2005 6 (1) 17-23
39. Del Zompo M, Cherchi A, Palmas M A. et al. Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 1998 51 (3) 781-786
40. Peroutka S J., Price S C., Wilhoit T L., Jones K W. Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Mol Med 1998 4 (1) 14-21
41. Peroutka S J., Wilhoit T, Jones K. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology 1997 49 (1) 201-206
42. Soragna D, Vettori A, Carraro G et al. A locus for migraine without aura maps on chromosome 14q21.2-q22.3. Am J Hum Genet 2003 72 (1) 161-167
43. Ogilvie A D., Russell M B., Dhall P et al. Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura. Cephalalgia 1998 18 (1) 23-26
44. Paterna S, Di Pasquale P, D'Angelo A et al. Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol 2000 43 (3) 133-136
45. McCarthy L C., Hosford D A., Riley J H. et al. Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics 2001 78 (3) 135-149
46. Emin Erdal M, Herken H, Yilmaz M, Bayazit Y A. Significance of the catechol-O-methyltransferase gene polymorphism in migraine. Brain Res Mol Brain Res 2001 94 (1-2) 193-196 (Pubitemid 32964760)
47. Nyholt D R., Dawkins J L., Brimage P J., Goadsby P J., Nicholson G A., Griffiths L R. Evidence for an X-linked genetic component in familial typical migraine. Hum Mol Genet 1998 7 (3) 459-463
48. Lashley K S. Patterns of cerebral integration indicated by the scotomas of migraine. Archives of Neurology and Psychiatry 1941 46 331-339
49. Leao A AP. Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944 7 359-390
50. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981 9 (4) 344-352
51. Lauritzen M, Skyhj Olsen T, Lassen N A., Paulson O B. Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol 1983 13 (6) 633-641 (Pubitemid 13103461)
52. Lauritzen M, Olesen J. Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. Brain 1984 107 (Pt 2) 447-461 (Pubitemid 14108830)
53. Olesen J, Friberg L, Olsen T S. et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990 28 (6) 791-798
54. Friberg L, Olsen T S., Roland P E., Lassen N A. Focal ischemia caused by instability of cerebrovascular tone during attacks of hemiplegic migraine. A regional cerebral blood flow study. Brain 1987 110 917-934
55. Andersen A R., Friberg L, Olsen T S., Olesen J. Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission computed tomographic demonstration. Arch Neurol 1988 45 154-159
56. Skyhj Olsen T, Friberg L, Lassen N A. Ischemia may be the primary cause of the neurologic deficits in classic migraine. Arch Neurol 1987 44 (2) 156-161
57. Warach S, Gaa J, Siewert B, Wielopolski P, Edelman R R. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 1995 37 (2) 231-241
58. Gardner-Medwin A R., van Bruggen N, Williams S R., Ahier R G. Magnetic resonance imaging of propagating waves of spreading depression in the anaesthetised rat. J Cereb Blood Flow Metab 1994 14 (1) 7-11
59. Hasegawa Y, Latour L L., Sotak C et al. Spreading waves of reduced diffusion coefficient of water in the rat brain. Neurology 1994 44 (Suppl 2) A34
60. Sanchez del Rio M, Bakker D, Wu O et al. Perfusion weighted imaging during migraine: Spontaneous visual aura and headache. Cephalalgia 1999 19 701-717
61. Sorensen A G., Rosen B R. Functional MRI of the brain. In: Magnetic Resonance Imaging of the Brain and Spine. 2nd Ed. Philadelphia Lippincott-Raven Publishers 1996
62. Cao Y, Welch K M., Aurora S, Vikingstad E M. Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol 1999 56 (5) 548-554
63. Cao Y, Aurora S K., Nagesh V, Patel S C., Welch K M. Functional MRI-BOLD of brainstem structures during visually triggered migraine. Neurology 2002 59 (1) 72-78
64. Hadjikhani N, Sanchez Del Rio M, Wu O et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 2001 98 (8) 4687-4692
65. Charles A. Intercellular calcium waves in glia. Glia 1998 24 (1) 39-49
66. Haydon P G., Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 2006 86 (3) 1009-1031
67. Chuquet J, Hollender L, Nimchinsky E A. High-resolution in vivo imaging of the neurovascular unit during spreading depression. J Neurosci 2007 27 (15) 4036-4044
68. Welch K M., Levine S R., D'Andrea G, Helpern J A. Brain pH during migraine: an in vivo phosphorus-31 magnetic resonance spectroscopy study. Cephalalgia 1988 8 273-277
69. Welch K M., Levine S R., D'Andrea G, Schultz L R., Helpern J A. Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology 1989 39 (4) 538-541
70. Welch K MA, Barkley G L., Ramadan N M., D'Andrea G. NMR spectroscopic and magnetoencephalographic studies in migraine with aura: support for the spreading depression hypothesis. Pathol Biol (Paris) 1992 40 (4) 349-354
71. Van Harreveld A, Fifkov E. Mechanisms involved in spreading depression. J Neurobiol 1973 4 (4) 375-387
72. Aurora S K., Welch K M., Al-Sayed F. The threshold for phosphenes is lower in migraine. Cephalalgia 2003 23 (4) 258-263
73. Ambrosini A, Schoenen J. Electrophysiological response patterns of primary sensory cortices in migraine. J Headache Pain 2006 7 (6) 377-388
74. Stankewitz A, May A. Cortical excitability and migraine. Cephalalgia 2007 27 (12) 1454-1456
75. Goadsby P J., Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990 28 (2) 183-187
76. Bolay H, Reuter U, Dunn A K., Huang Z, Boas D A., Moskowitz M A. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002 8 (2) 136-142
77. Moskowitz M A., Nozaki K, Kraig R P. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 1993 13 (3) 1167-1177
78. Kraig R P., Nicholson C. Extracellular ionic variations during spreading depression. Neuroscience 1978 3 (11) 1045-1059
79. Obrenovitch T P., Urenjak J, Wang M. Nitric oxide formation during cortical spreading depression is critical for rapid subsequent recovery of ionic homeostasis. J Cereb Blood Flow Metab 2002 22 (6) 680-688
80. Lauritzen M, Hansen A J., Kronborg D, Wieloch T. Cortical spreading depression is associated with arachidonic acid accumulation and preservation of energy charge. J Cereb Blood Flow Metab 1990 10 (1) 115-122
81. Gursoy-Ozdemir Y, Qiu J, Matsuoka N et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 2004 113 (10) 1447-1455
82. Eikermann-Haerter K, Dilekz E, Kudo C et al. Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest 2009 119 (1) 99-109
83. Afridi S K., Matharu M S., Lee L et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 2005 128 (Pt 4) 932-939
84. May A, Kaube H, Bchel C et al. Experimental cranial pain elicited by capsaicin: a PET study. Pain 1998 74 (1) 61-66
85. Strassman A M., Raymond S A., Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature 1996 384 (6609) 560-564
86. Moskowitz M A., Buzzi M G. Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions. J Neurol 1991 238 (Suppl 1) S18-S22
87. Moskowitz M A., Cutrer F M. Possible importance of neurogenic inflammation within the meninges to migraine headaches In: Fields HL, Liebeskind JC Progress in Pain Research and Management. Seattle IASP Press 1993 43-49
88. Burstein R, Yamamura H, Malick A, Strassman A M. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 1998 79 (2) 964-982
89. Yamamura H, Malick A, Chamberlin N L., Burstein R. Cardiovascular and neuronal responses to head stimulation reflect central sensitization and cutaneous allodynia in a rat model of migraine. J Neurophysiol 1999 81 (2) 479-493
90. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil B J., Bajwa Z H. An association between migraine and cutaneous allodynia. Ann Neurol 2000 47 (5) 614-624
91. Burstein R, Cutrer M F., Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2000 123 (Pt 8) 1703-1709
92. Sand T, Zhitniy N, Nilsen K B., Helde G, Hagen K, Stovner L J. Thermal pain thresholds are decreased in the migraine preattack phase. Eur J Neurol 2008 15 (11) 1199-1205
93. Shields K G., Goadsby P J. Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine? Brain 2005 128 (Pt 1) 86-97
94. Welch K M., Nagesh V, Aurora S K., Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 2001 41 (7) 629-637
95. Kruit M C., Launer L J., Overbosch J, van Buchem M A., Ferrari M D. Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study. Cephalalgia 2009 29 (3) 351-359
96. Aurora S K., Barrodale P M., Tipton R L., Khodavirdi A. Brainstem dysfunction in chronic migraine as evidenced by neurophysiological and positron emission tomography studies. Headache 2007 47 (7) 996-1003, discussion 10041007
97. Kruit M C., van Buchem M A., Hofman P A. et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004 291 (4) 427-434
98. Kruit M, van Buchem M, Launer L, Terwindt G, Ferrari M. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia 2009 Epub ahead of print
99. Rozen T D. Vanishing cerebellar infarcts in a migraine patient. Cephalalgia 2007 27 (6) 557-560
100. Schwedt T J., Demaerschalk B M., Dodick D W. Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia 2008 28 (5) 531-540
101. Anzola G P., Frisoni G B., Morandi E, Casilli F, Onorato E. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke 2006 37 (2) 430-434
102. Reisman M, Christofferson R D., Jesurum J et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005 45 (4) 493-495
103. Dowson A, Mullen M J., Peatfield R et al. Migraine Intervention With STARFlex Technology (MIST) Trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008 117 (11) 1397-1404
104. Adami A, Rossato G, Cerini R et al., on behalf of the SAM Study Group. Right-to-left shunt does not increase white matter lesion load in migraine with aura patients. Neurology 2008 71 (2) 101-107